Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$513,251,732
+$125,437,150 QoQ
Shares Held
427,913
+1.5% QoQ
Ownership
0.045%
of shares outstanding
% of Portfolio
1.55%
of 13F equity value
Holder Rank
#141
of 4,605 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LORD, ABBETT & CO. LLC holds $1,248,570,920 across 7 Drug Manufacturers - General names. LLY ranks #1 (41.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
427,913 | $513,251,732 | |
| 2 | JNJ |
Johnson & Johnson
|
1,477,212 | $375,167,531 | |
| 3 | NVS |
Novartis AG
|
1,002,335 | $157,085,941 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
929,682 | $117,456,023 | |
| 5 | ABBV |
AbbVie Inc.
|
180,108 | $45,322,377 | |
| 6 | BIIB |
Biogen Inc.
|
130,184 | $28,127,555 | |
| 7 | AZN |
Astrazeneca PLC
|
64,127 | $12,159,761 |
All Filings in LLY
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $513,251,732 | 427,913 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $387,814,582 | 421,643 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $274,855,883 | 255,756 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $83,716,360 | 109,720 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $114,932,344 | 147,438 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $184,146,545 | 222,962 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $111,793,320 | 144,810 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $334,894,179 | 378,010 | Shares | Sole | 2024-12-13 | |
| 2024-06-30 | $407,410,135 | 449,988 | Shares | Sole | 2024-10-07 | |
| 2024-03-31 | $322,902,411 | 415,063 | Shares | Sole | 2024-10-07 | |
| 2023-12-31 | $264,102,398 | 453,068 | Shares | Sole | 2024-10-07 | |
| 2023-09-30 | $324,912,622 | 604,905 | Shares | Sole | 2024-10-07 | |
| 2023-06-30 | $293,905,545 | 626,691 | Shares | Sole | 2024-10-07 | |
| 2023-03-31 | $149,198,819 | 434,450 | Shares | Sole | 2024-10-07 | |
| 2022-12-31 | $319,543,679 | 873,452 | Shares | Other | 2024-10-07 | |
| 2022-09-30 | $318,208,734 | 984,100 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $236,739,776 | 730,160 | Shares | Other | 2022-08-12 | |
| 2022-03-31 | $146,625,162 | 512,013 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $178,211,342 | 645,179 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $150,527,225 | 651,492 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $144,804,167 | 630,900 | Shares | Other | 2021-08-11 | |
| 2021-03-31 | $145,384,257 | 778,205 | Shares | Other | 2021-05-11 | |
| 2020-12-31 | $92,322,049 | 546,802 | Shares | Sole | 2021-02-09 | |
| No filing history on record for this holder in this stock. | ||||||